These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 25925126)

  • 1. Homoharringtonine, a clinically approved anti-leukemia drug, sensitizes tumor cells for TRAIL-induced necroptosis.
    Philipp S; Sosna J; Plenge J; Kalthoff H; Adam D
    Cell Commun Signal; 2015 Apr; 13():25. PubMed ID: 25925126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The plant alkaloid and anti-leukemia drug homoharringtonine sensitizes resistant human colorectal carcinoma cells to TRAIL-induced apoptosis via multiple mechanisms.
    Beranova L; Pombinho AR; Spegarova J; Koc M; Klanova M; Molinsky J; Klener P; Bartunek P; Andera L
    Apoptosis; 2013 Jun; 18(6):739-50. PubMed ID: 23456623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Homoharringtonine and SAHA synergistically enhance apoptosis in human acute myeloid leukemia cells through upregulation of TRAIL and death receptors.
    Cao H; Cheng Y; You L; Qian J; Qian W
    Mol Med Rep; 2013 Jun; 7(6):1838-44. PubMed ID: 23620163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of the resistance to TRAIL-induced apoptosis as a new strategy for pancreatic cancer.
    Mori T; Doi R; Toyoda E; Koizumi M; Ito D; Kami K; Kida A; Masui T; Kawaguchi Y; Fujimoto K
    Surgery; 2005 Jul; 138(1):71-7. PubMed ID: 16003319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human embryonic and induced pluripotent stem cells express TRAIL receptors and can be sensitized to TRAIL-induced apoptosis.
    Vinarsky V; Krivanek J; Rankel L; Nahacka Z; Barta T; Jaros J; Andera L; Hampl A
    Stem Cells Dev; 2013 Nov; 22(22):2964-74. PubMed ID: 23806100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of Akt signaling by the lignan matairesinol sensitizes prostate cancer cells to TRAIL-induced apoptosis.
    Peuhu E; Rivero-Müller A; Stykki H; Torvaldson E; Holmbom T; Eklund P; Unkila M; Sjöholm R; Eriksson JE
    Oncogene; 2010 Feb; 29(6):898-908. PubMed ID: 19935713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homoharringtonine acts synergistically with SG235-TRAIL, a conditionally replicating adenovirus, in human leukemia cell lines.
    Meng HT; Li L; Liu H; Wang Y; Li GC; Qian WB
    Acta Pharmacol Sin; 2009 Nov; 30(11):1529-36. PubMed ID: 19820719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences and Similarities in TRAIL- and Tumor Necrosis Factor-Mediated Necroptotic Signaling in Cancer Cells.
    Sosna J; Philipp S; Fuchslocher Chico J; Saggau C; Fritsch J; Föll A; Plenge J; Arenz C; Pinkert T; Kalthoff H; Trauzold A; Schmitz I; Schütze S; Adam D
    Mol Cell Biol; 2016 Oct; 36(20):2626-44. PubMed ID: 27528614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CCAAT/enhancer binding protein homologous protein-dependent death receptor 5 induction and ubiquitin/proteasome-mediated cellular FLICE-inhibitory protein down-regulation contribute to enhancement of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by dimethyl-celecoxib in human non small-cell lung cancer cells.
    Chen S; Liu X; Yue P; Schönthal AH; Khuri FR; Sun SY
    Mol Pharmacol; 2007 Nov; 72(5):1269-79. PubMed ID: 17684158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downmodulation of dimethyl transferase activity enhances tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in prostate cancer cells.
    Festuccia C; Gravina GL; D'Alessandro AM; Millimaggi D; Di Rocco C; Dolo V; Ricevuto E; Vicentini C; Bologna M
    Int J Oncol; 2008 Aug; 33(2):381-8. PubMed ID: 18636160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of elevated pressure in TRAIL-induced apoptosis in human lung carcinoma cells.
    Oh S; Kwon D; Lee HJ; Kim J; Lee E
    Apoptosis; 2010 Dec; 15(12):1517-28. PubMed ID: 20623193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TRAIL as a target in anti-cancer therapy.
    Wu GS
    Cancer Lett; 2009 Nov; 285(1):1-5. PubMed ID: 19299078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble TNF-like weak inducer of apoptosis (TWEAK) enhances poly(I:C)-induced RIPK1-mediated necroptosis.
    Anany MA; Kreckel J; Füllsack S; Rosenthal A; Otto C; Siegmund D; Wajant H
    Cell Death Dis; 2018 Oct; 9(11):1084. PubMed ID: 30349023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic anti-cancer effects via co-delivery of TNF-related apoptosis-inducing ligand (TRAIL/Apo2L) and doxorubicin using micellar nanoparticles.
    Lee AL; Dhillon SH; Wang Y; Pervaiz S; Fan W; Yang YY
    Mol Biosyst; 2011 May; 7(5):1512-22. PubMed ID: 21350763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NF-kappaB-independent actions of sulfasalazine dissociate the CD95L- and Apo2L/TRAIL-dependent death signaling pathways in human malignant glioma cells.
    Hermisson M; Weller M
    Cell Death Differ; 2003 Sep; 10(9):1078-89. PubMed ID: 12934082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination of Ad-sTRAIL with the chemotherapeutic drug cisplatin synergistically enhances their pro-apoptotic ability in human breast cancer cells.
    Liu X; Wang J; Wang H; Liu S; Liang Y; Lv Z; Zhou Q; Ding W
    Oncol Rep; 2013 Oct; 30(4):1913-9. PubMed ID: 23912708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Artesunate enhances TRAIL-induced apoptosis in human cervical carcinoma cells through inhibition of the NF-κB and PI3K/Akt signaling pathways.
    Thanaketpaisarn O; Waiwut P; Sakurai H; Saiki I
    Int J Oncol; 2011 Jul; 39(1):279-85. PubMed ID: 21537836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aclarubicin enhances tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis through death receptor 5 upregulation.
    Horinaka M; Yoshida T; Nakata S; Shiraishi T; Tomosugi M; Yoshikawa S; Wakada M; Sakai T
    Cancer Sci; 2012 Feb; 103(2):282-7. PubMed ID: 22077238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The dietary isoflavone biochanin-A sensitizes prostate cancer cells to TRAIL-induced apoptosis.
    Szliszka E; Czuba ZP; Mertas A; Paradysz A; Krol W
    Urol Oncol; 2013 Apr; 31(3):331-42. PubMed ID: 21803611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of vacuolar ATPase attenuates the TRAIL-induced activation of caspase-8 and modulates the trafficking of TRAIL receptosomes.
    Horova V; Hradilova N; Jelinkova I; Koc M; Svadlenka J; Brazina J; Klima M; Slavik J; Hyrslova Vaculova A; Andera L
    FEBS J; 2013 Jul; 280(14):3436-50. PubMed ID: 23678861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.